Industrial Goods » Industrial Electronics | HLB Life Science Co. Ltd.

HLB Life Science Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
19,956
36,560
27,323
42,234
106,445
Cost of Goods Sold (COGS) incl. D&A
20,303
31,729
32,330
39,099
101,339
Gross Income
348
4,831
5,006
3,135
5,106
SG&A Expense
2,913
3,266
5,242
4,222
4,414
EBIT
3,288
1,520
10,534
1,144
444
Unusual Expense
-
61
4,950
343
5,660
Non Operating Income/Expense
180
326
110
453
3,096
Interest Expense
1,239
1,059
1,833
960
1,547
Pretax Income
3,481
1,315
16,843
914
7,834
Income Tax
964
17
198
39
73
Equity in Affiliates
1
-
-
298
-
Consolidated Net Income
4,446
1,331
17,041
1,251
7,761
Net Income
4,446
1,331
17,041
1,251
7,761
Net Income After Extraordinaries
4,817
1,260
17,041
1,251
7,761
Net Income Available to Common
4,074
1,403
17,041
1,251
7,761
EPS (Basic)
484.29
99.12
1,011.05
50.03
305.86
Basic Shares Outstanding
8
14
17
25
25
EPS (Diluted)
484.23
99.24
1,011.20
49.90
305.88
Diluted Shares Outstanding
8
14
17
25
25
EBITDA
2,731
2,056
9,820
796
762
Other Operating Expense
27
46
286
57
248
Non-Operating Interest Income
866
588
363
394
228
Equity in Affiliates (Pretax)
-
-
-
-
46

About HLB Life Science Co.

View Profile
Address
A-602 JnK Digital Tower
Seoul SL 08390
Korea, Republic Of
Employees -
Website http://www.hlb-ls.com
Updated 09/14/2018
HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. It operates through the Bio and Energy Saving Company(ESCO) Businesses. The Bio business researches and develops pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.